These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21555309)

  • 21. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development and validation of risk score model for acute myocardial infarction in China: prognostic value thereof for in hospital major adverse cardiac events and evaluation of revascularization].
    Wu XF; Lü SZ; Chen YD; Pan WQ; Song XT; Li J; Liu X; Wang XZ; Zhang LJ; Ren F; Luo JG;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1815-9. PubMed ID: 19040015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratification.
    Yan AT; Yan RT; Tan M; Chow CM; Fitchett DH; Georgescu AA; Hassan Q; Luchansky J; Langer A; Goodman SG;
    Am Heart J; 2006 Aug; 152(2):270-6. PubMed ID: 16875907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].
    Kiliç T; Ural E; Oner G; Sahin T; Kiliç M; Yavuz S; Kanko M; Kahraman G; Bildirici U; Berki KT; Ural D
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):280-9. PubMed ID: 19666429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein on admission as a predictor of in-hospital death in the elderly with acute myocardial infarction.
    Gheno G; Libardoni M; Zeppellini R; Cucchini F
    Cardiologia; 1999 Dec; 44(12):1023-8. PubMed ID: 10687251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
    Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
    J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function.
    Aronson D; Hammerman H; Kapeliovich MR; Suleiman A; Agmon Y; Beyar R; Markiewicz W; Suleiman M
    Diabetes Care; 2007 Apr; 30(4):960-6. PubMed ID: 17392556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
    Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE).
    Steg PG; Dabbous OH; Feldman LJ; Cohen-Solal A; Aumont MC; López-Sendón J; Budaj A; Goldberg RJ; Klein W; Anderson FA;
    Circulation; 2004 Feb; 109(4):494-9. PubMed ID: 14744970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction.
    Zeller M; Steg PG; Ravisy J; Laurent Y; Janin-Manificat L; L'Huillier I; Beer JC; Oudot A; Rioufol G; Makki H; Farnier M; Rochette L; Vergès B; Cottin Y;
    Arch Intern Med; 2005 May; 165(10):1192-8. PubMed ID: 15911735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro-substance p for evaluation of risk in acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Struck J; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Oct; 64(16):1698-707. PubMed ID: 25323258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction.
    Sanchis J; Bodí V; Llácer A; Núñez J; Facila L; Ruiz V; Blasco M; Sanjuán R; Chorro FJ
    Am J Cardiol; 2004 Sep; 94(6):766-9. PubMed ID: 15374783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
    Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL
    Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].
    Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M
    Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction.
    Al Aseri ZA; Habib SS; Marzouk A
    Vasc Health Risk Manag; 2019; 15():221-227. PubMed ID: 31410012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.